Kairos Pharma (KAPA) Stock: Buy, Sell, or Hold?
KAPA - Kairos Pharma, Ltd.
$0.56
0.01 (2.67%)
▲
5d:
-7.12%
30d:
-68.45%
90d:
+80.28%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 13, 2026
19d
Get Alerted When KAPA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KAPA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KAPA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KAPA is currently trading at $0.56, which is considered oversold relative to its 30-day fair value range of $0.75 to $1.77.
Technical Outlook: Technically, KAPA is in a strong uptrend. Immediate support is located at $0.52, while resistance sits at $0.84.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $49.00 (+8673.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KAPA is in a strong uptrend. Immediate support is located at $0.52, while resistance sits at $0.84.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $49.00 (+8673.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.75 -
$1.77
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: Trading 8673.9% below Wall St target ($49.00)
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
- CAUTION: 5-day price weakness (-7.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.75 -
$1.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.52
Resistance Level
$0.84
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.12
Wall Street Target
$49.00
(+8673.9%)
Share & Embed Analysis
Last updated: October 23, 2026 11:31 PM ET
Data refreshes hourly during market hours. Next update: 12:31 AM
Data refreshes hourly during market hours. Next update: 12:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KAPA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 64 BUY |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 35 SELL |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 65 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 61 BUY |
